Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin for Preemptive Analgesia in Third Molar Extraction
NCT00088686Phase 2
Key facts
- Status
- Completed
- Start
- Jul 2004
- Countries
- 1
- Sponsor
- National Institute of Dental and Craniofacial Research
- Modality
- Small Molecules
- Drugs
- capsaicin
- Conditions
- postoperative pain
01
Overview
Phase 2, randomised, double-blind trial of capsaicin in postoperative pain (3 arms), sponsored by National Institute of Dental and Craniofacial Research. Primary endpoints: Pain Ratings at 6 hours and Time to Analgesic Rescue Medication Request at 6 hours. Started Jul 2004; status: completed.
02
Design
3 arms- Study design
- RandomizedDouble-blind
Capsaicin
Intramucosal Capsaicin + IV Placebo
Ketorolac
Intramucosal Placebo + IV Ketorolac
Placebo
Intramucosal Placebo + IV Placebo
03
Endpoints
Primary
Pain Ratings
Time to Analgesic Rescue Medication Request
Secondary
Analgesic Use
Beyond the preview
Go deeper on NCT00088686.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088686.